Estimating the residual risk for <scp>HIV</scp>,<scp> HCV</scp> and <scp>HBV</scp> in different types of platelet concentrates in Germany
Matthias an der Heiden(Robert Koch Institute), Ruth Offergeld(Robert Koch Institute), Osamah Hamouda(Robert Koch Institute), S. Ritter(Robert Koch Institute)
Cited by 19
Related Papers
Epidemic Profile of Shiga-Toxin–Producing<i>Escherichia coli</i>O104:H4 Outbreak in Germany
|New England Journal of Medicine|2011|1.1k
German Outbreak of<i>Escherichia coli</i>O104:H4 Associated with Sprouts
|New England Journal of Medicine|2011|718
Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020
|Eurosurveillance|2020|238